Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE‐HF model
PM Burger, G Savarese, J Tromp… - European Journal of …, 2023 - Wiley Online Library
Aims Although trials have proven the group‐level effectiveness of various therapies for heart
failure with reduced ejection fraction (HFrEF), important differences in absolute effectiveness …
failure with reduced ejection fraction (HFrEF), important differences in absolute effectiveness …
Long-term use of ipragliflozin improved cardiac sympathetic nerve activity in a patient with heart failure: a case report
S Kiuchi, S Hisatake, T Kabuki, T Fujii, T Oka… - Drug discoveries & …, 2018 - jstage.jst.go.jp
Ipragliflozin is the first SGLT2 inhibitor approved in Japan. Reported here is a case where
long-term administration of ipragliflozin decreased the rate of re-hospitalization due to heart …
long-term administration of ipragliflozin decreased the rate of re-hospitalization due to heart …
Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1–7) concentration in patients with acute heart failure patients requiring emergency …
S Hisatake, S Kiuchi, T Kabuki, T Oka, S Dobashi… - Heart and vessels, 2017 - Springer
The existence of a new cascade, angiotensin-converting enzyme (ACE) 2/angiotensin (Ang)-
(1–7)/Mas receptor axis, has been recently established in the renin–angiotensin system …
(1–7)/Mas receptor axis, has been recently established in the renin–angiotensin system …
Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement …
S Matsumoto, G Nakazawa, Y Ohno… - ESC Heart …, 2020 - Wiley Online Library
Aims Exogenous atrial natriuretic peptide (ANP) may be a logical treatment for heart failure
(HF) patients with ANP deficiency. Lower ANP concentrations may result from HF with …
(HF) patients with ANP deficiency. Lower ANP concentrations may result from HF with …
[HTML][HTML] Pulse pressure and upstroke time are useful parameters for the diagnosis of peripheral artery disease in patients with normal ankle brachial index
S Kiuchi, S Hisatake, I Watanabe, M Toda… - Cardiology …, 2016 - ncbi.nlm.nih.gov
Background Some peripheral artery disease (PAD) patients have normal ankle brachial
index (ABI)(0.9-1.4), although ABI is a useful parameter for the diagnosis of PAD. We …
index (ABI)(0.9-1.4), although ABI is a useful parameter for the diagnosis of PAD. We …
Comparison of Direct Oral Anticoagulants and Warfarin in the Treatment of Deep Venous Thrombosis in the Chronic Phase A Large, Single-Center, Observational …
S Wakakura, F Hara, T Fujino, A Hamai… - International Heart …, 2018 - jstage.jst.go.jp
We assessed the efficacy and safety of direct oral anticoagulants (DOACs) for the treatment
of deep venous thrombosis (DVT) in the chronic phase through comparison with …
of deep venous thrombosis (DVT) in the chronic phase through comparison with …
A case of sinus arrest and post-hiccup cough syncope in medullary infarction
T Takazawa, K Ikeda, O Kano, T Kabuki… - Journal of Stroke and …, 2014 - Elsevier
We describe asymptomatic sinus arrest and post-hiccup cough syncope in a patient with
medullary infarction. A 78-year-old woman developed arrhythmia, hiccup, and cough …
medullary infarction. A 78-year-old woman developed arrhythmia, hiccup, and cough …
The relationship between the time until commencement of tolvaptan and the length of hospital stay in heart failure patients
S Kiuchi, S Hisatake, T Kabuki, T Oka, S Dobashi… - Heart and Vessels, 2018 - Springer
The effect of early use of tolvaptan (TLV) for acute decompensated heart failure (ADHF) is
unclear. We investigated the relationship between early use of TLV and the length of …
unclear. We investigated the relationship between early use of TLV and the length of …
[HTML][HTML] Efficacy of intravenous administration of landiolol in patients with acute heart failure and supraventricular tachyarrhythmia
S Kiuchi, H Aikawa, S Hisatake, T Kabuki… - Journal of clinical …, 2017 - ncbi.nlm.nih.gov
Background Patients with acute heart failure (HF) complicated by supraventricular
tachyarrhythmia (SVT) often receive continuous intravenous infusion of landiolol or diltiazem …
tachyarrhythmia (SVT) often receive continuous intravenous infusion of landiolol or diltiazem …
Bisoprolol transdermal patch improves orthostatic hypotension in patients with chronic heart failure and hypertension
S Kiuchi, S Hisatake, T Kabuki, T Oka… - Clinical and …, 2020 - Taylor & Francis
ABSTRACT β blockers (BBs) play an important role in heart failure (HF) treatment. However,
orthostatic hypotension (OH) is sometimes caused by BBs. The bisoprolol transdermal patch …
orthostatic hypotension (OH) is sometimes caused by BBs. The bisoprolol transdermal patch …